Quote

ScreenCell Technology :
A Circulating Tumor Cells Test

Liquid biopsy technology dedicated to the capture of circulating tumor cells

ScreenCell technology is a versatile liquid biopsy technology designed to capture Circulating Tumor Cells (CTCs) non-invasively from a simple blood sample in patients with solid cancers.

ScreenCell technology has been developed into 7 single-use kits dedicated to the isolation of circulating tumor cells. Each kit is designed for distinct and specific applications.

Multiple reasons to use our circulating tumor cells test in your research and clinical routine

The easiest-to-use circulating tumor cells test.

Device CYTO et MB - 2 dispositifs ScreenCell de détection des cellules tumorales circulantes
Single-use and non-invasive device.
Fast filtration process of less than 3 min.
No additional equipment required for CTCs isolation.
Size-based capture system.
One of the most affordable circulating tumor cells test on the market.
A recovery rate greater than 90%.

Our filtration units

Discover our two filtration devices: CYTO and MB.

They are both equipped with a specific isolation support, thus offering a multitude of applications in cytology, molecular biology and cell culture.

Device CYTO

CYTO
filtration unit

CYTO
isolation support

Device MB

MB
filtration unit

MB
isolation support

Simplicity in your hands

ScreenCell technology stands out from other methods due to its remarkable ease of use.

In fact, our circulating tumor cells test offer its users the possibility of efficiently and quickly capturing CTCs, thanks to the absence of any machine constraints in just 3 simple steps: dilution, filtration and ejection.

A commitment to the environment

For more than 10 years, ScreenCell has chosen to develop its expertise in collaboration with local suppliers and partners in order to promote excellence and French and European national know-how. 

We are committed to providing our customers with quality products and we believe this requires controlled production, from design to manufacturing. 

We carefully select the raw materials used in our circulating tumor cells test and we work in close collaboration with French and European companies to guarantee an impeccable level of finish. 

Which kit is right for my application ?

Use our test to find out which ScreenCell kit is right for you.

Find the perfect solution in just a few clicks.

Learn more
circulating tumor cells test in bulk
circulating tumor cells test in bulk

Frequently Asked Questions

ScreenCell technology is specifically designed for use on solid cancers, such as breast, lung, prostate, colon and many others.

This technology is not suitable for hematological cancers, such as leukemia or lymphoma, which affect the blood or lymphatic organs without forming solid tumors.

Our circulating tumor cells test is designed to be used stand-alone without the need for any specific additional equipment.

However, for some more advanced analyses, you may need additional equipment such as digital PCR or FACS for more detailed examinations or additional tests.

ScreenCell technology offers two types of filtration devices adapted to different needs:

The Cyto Device is designed to filter 3 ml blood samples.
This device is often used for cytology analyses.

The MB Device is designed to filter 6 ml blood samples.
This device is often used for molecular biology or cell culture analyses.

After performing filtration with ScreenCell technology, you can undertake a multitude of analyses and applications thanks to our three fields of application which are cytology, molecular biology and cell culture.

Yes, we offer technical support and training to ensure optimal use of ScreenCell technology.

If you need technical assistance or training to understand and use our filtration devices, you can request a support.

To arrange a training session or obtain technical assistance, please contact our technical support.

Liquid biopsy for
enhancing patient care through reliable CTC analysis
Request a quote